The state Senate of New York is on the brink of passing a package of health affordability bills that could significantly impact the lives of working- and middle-class people. This move is part of the Democrats’ focus on ‘affordability’ as a key theme in this election year. The package includes a bill that would allow the state to enter into contracts with private manufacturers to produce generic drugs, and another that would permit New Yorkers to start importing medicine from Canada.
Majority Leader Andrea Stewart-Cousins stated at a news conference, ‘We are very clear that we are here to fight for working- and middle-class people. We’re here to serve the people, to address their needs, to prioritize issues that we know matter to most working families.’
However, it’s worth noting that most of these bills had previously passed the Senate in 2023 but stalled in the Assembly. This has become a recurring theme early in the 2024 session. The two houses have each passed a selection of bills that were approved by only their chamber last year, but stalled in the other.
As January winds down, there’s not much time left for any major two-way agreements before the budget due at the end of March takes precedence. ‘We’re always in conversations with our colleagues in the Assembly,’ Stewart-Cousins said. ‘At this point, we are pretty much ensconced in the budget conversations. I could just tell you to stay tuned, I’m not promising anything, but we always are working very, very closely with our colleagues in the Assembly.’
This information was sourced from Politico.